Our Mission

To improve the quality of life of patients around the world through the development and delivery of high quality, innovative and easy to use therapeutic solutions.

Our Company Shared Values – TEAMWORK

  • teamwork-t

    Trust

    in each other

  • teamwork-e

    Excellence

    in everything we do

  • teamwork-a

    Accountability

    for actions and results

  • teamwork-m

    Market Driven

    decision making

  • teamwork-w

    Willingness

    to learn and grow

  • teamwork-o

    Open Minded

    to new ideas and change

  • teamwork-r

    Respect

    for self and others

  • teamwork-k

    Knowledgeable

    of our business and goals

Our Story

You may have heard of Repro Med Systems, Inc. That’s us! Today, we are operating as RMS Medical Products, a leading developer and manufacturer of medical devices and supplies. The company was incorporated in March, 1980 and is now publicly traded . Our stock symbol is REPR.

Worldwide, RMS Medical Products drives healthcare inspiration – in the minds of our patients, our employees, our customers and our shareholders – to give everyone greater freedom for living. We design and manufacture safe, affordable medical devices to make quality healthcare a reality for everyone.

We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers, and careful consideration for the patient experience. Our primary products are the FREEDOM60® and FreedomEdge® DynEQ Infusion Systems, RMS Precision Flow Rate Tubing™, HIgH-Flo Subcutaneous Safety Needle Sets™ and RES-Q-VAC® Hand Held Medical Suction.

We are passionate about helping people with our reliable medical devices made at our HQ in Chester, NY (USA). Our products, as well as product support, are offered worldwide by RMS and through a global network of distributors and service providers.

RMS is excited to expand into new markets with innovative, more technical products. We look forward to productive partnerships with people and companies who share our vision and can help us effectively deliver our value promise to stakeholders in our industry.

Our Latest News & Updates

District Judge Issues Final Judgment in Favor of RMS Medical Products

CHESTER, NY – July 2, 2019 – Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS Medical” or “the Company”) today announced that on June 28, 2019 the United States District Judge for the Eastern District of Texas (Case No. 2:15-CV-01167-JRG-RSP) issued a Final Judgment in favor of RMS Medical in the Company’s … Continued

Meet Our Executive Team

  • Daniel S. Goldberger

    Executive Chairman

    Mr. Goldberger was appointed to Executive Chairman of the Board of Directors on February 1, 2019, previously serving as Chairman and interim Chief Executive Officer.  Mr. Goldberger has over 35 years of experience within the biotech, medical technology, and high tech industries.  His areas of expertise include mergers and acquisitions, capital formation, intellectual property, product development, supply chain, business analytics, and turnarounds.   Since January 2018, Mr. Goldberger is the Chief Executive Officer of Synergy Disc Replacement Inc., a private company commercializing a proprietary total disc implant for cervical spine therapy. Mr. Goldberger served as Chief Executive Officer of Milestone Medical, Inc. until October 2017. Prior to this, he served as the Chief Executive Officer of Xtant Medical Holdings, Inc. from August 2013 to January 2017. He also served as the Chief Executive Officer of Sound Surgical Technologies LLC from April 2007 to February 2013. Mr. Goldberger served on the boards of Xtant Medical Holdings, Inc., Sound Surgical, Xcorporeal and Glucon. He currently serves as an advisor to investment funds with Meridian Capital and Wellfleet Capital. Mr. Goldberger earned his B.S. in Mechanical Engineering from M.I.T, his M.S. in Mechanical Engineering from Stanford University and attended the Stanford Directors College.

    Committee Memberships: Governance & Nomination

  • Donald B. Pettigrew

    President and Chief Executive Officer

    Mr. Pettigrew was appointed to Chief Executive Officer February 1, 2019, previously serving as Chief Commercial Officer for RMS. Mr. Pettigrew has more than 23 years of sales and business development experience in the medical device industry, including the home infusion space. Mr. Pettrigrew has held senior leadership positions at market leading medical firms such as Moog, Inc., Baxter (formerly Gambro) and Boston Scientific. At Moog, he held senior roles from 2011 to 2018 as Group Director, Global Business Development and Group Director, and Global Sales and Professional Services where he led commercialization and business development for the IV infusion and enteral feeding franchises in both the U.S. and international markets. While at Moog, he helped the medical division grow sales and profitability to well over one hundred million dollars. Mr. Pettigrew holds a BA in Biology from the University of Colorado, Boulder.

  • Karen Fisher

    Chief Financial Officer

    Karen Fisher has more than 25 years of financial experience in a variety of industries, most recently serving as the Assistant Controller for a global consumer products company. She has also held roles including Chief Accounting Officer and Treasurer and Controller. Ms. Fisher held multiple financial management roles covering financial analysis and reporting, budgeting, forecasting, acquisitions, and cash management.  She is thoroughly knowledgeable in compliance with SEC regulation, GAAP, 10Q’s, 10K’s, and Sarbanes-Oxley.  Ms. Fisher is a Certified Public Accountant and a graduate of Arizona State University with a BS in Accounting.

  • Manuel Marques

    Chief Operating Officer

    Manuel Marques joined RMS in 2015 as Director of Manufacturing/Manufacturing Engineering with an engineering background in FDA Class II & III medical devices. In 2016, he became the VP of Operations. Most recently, Mr. Marques was promoted to Chief Operations Officer as a recognition of the leadership and responsibilities he has undertaken, and of his tremendous contributions to the company. He has a proven history of effectively transferring new products from R&D into Manufacturing, while also reducing operating and manufacturing costs of existing products. Mr. Marques is a champion at enhancing operational management via implementation of Lean 6-Sigma Manufacturing techniques. Mr. Marques holds two U.S. patents for cardiovascular medical devices. Mr. Marques obtained a BS in Mechanical Engineering Technology and also an MS in Engineering Management from the New Jersey Institute of Technology.

  • Brian Schiller, PhD

    Vice President of Medical Affairs

    Dr. Brian Schiller brings 20 years of leadership and executional expertise in Clinical Development and Medical Affairs including domestic and global strategic development, product development/launch, cross-functional alignment, field medical strategy, professional medical education & communications, and company-sponsored & extramural clinical research.  Dr. Schiller has previously served in Clinical and Medical Affairs roles with increasing responsibility at Bristol Myers-Squibb, Amgen, and Avanir and has been involved in product development and launch for innovative therapies including Kineret, Enbrel, Nuedexta, Seprafilm, and Synvisc.  Dr. Schiller most recently spent 10 years at Genzyme/Sanofi as Senior Director and Head of Field Medical, North America Medical Affairs.  Dr. Schiller earned his Master’s degree in Kinesiology/Physiology and his Doctorate (Ph.D.) in Applied Physiology from the University of Colorado-Boulder.

  • Craig Ross

    Vice President of Sales & Marketing

    Craig Ross is joined RMS on July 1, 2019 as our Vice President of Sales and Marketing.

    Craig graduated from Durban University of Technology, in South Africa, with a Bachelor of Business Administration, Marketing.  Craig has a wealth of industry experience and an impressive career history, including having held several senior roles at Coram/CVS Specialty Infusion services, one of our largest customers, ending his tenure there as Senior Vice President, General Manager and Director, Enteral Operations. Craig also spent several years at Baxalta as Area Vice President, US Hemophilia Sales.  His latest role prior to joining us was Chief Customer Officer at MedSpeed LLC.

  • John Toomey

    Vice President of Growth & Innovation

    John Toomey brings with him over 30 years of medical device industry experience as an executive, patent officer, inventor, board member, and advisor. Mr. Toomey holds 24 U.S. and foreign patents.

    Mr. Toomey will be responsible for research and development, product innovation, and business development, as well as integrating these capabilities across the enterprise. He will also play a key role in building a robust IP platform. Mr. Toomey has held leadership roles at numerous medical device companies, including Pneuma Systems Corporation, Validose, Inc., Halkey-Roberts Corporation, Smith’s Medical, Inc., and CR Bard (acquired by Becton Dickinson). He also founded 2ME Mgmt Consultancy, LLC, which specialized in developing latent market opportunities and solving project, regulatory, and IP challenges in the medical device space.

    Mr. Toomey received his BS from Allegheny College, MBA from the Marshall School of Business at the University of Southern California, and JD from Thomas Jefferson School of Law.

Investor Relations